|
|
|
|
||
Re: CONFERENCE Your welcome. Thought so myself as this is contrary to someone else saying, 'next year'... Doesn't even sound like they are anywhere near putting together an IDE request either does it if they are modifying things, including the software at this stage... Yep, the statement that 2023 is the year is more inline with what I said earlier when one considers the duration of what still has to happen: -get the mods implemented and see if further mods are required -create a test program to show its ready to conduct an IDE -submit the IDE for FDA review (How many months does this take to get done??) -execute the IDE -package the results for FDA submission -FDA review yeah, 2023 sounds about right.. disclaimer: yep a contrarian investor.. from the aspect of one who practices the approach that there is a time to buy and trade, and eventually one reaches a time to buy and hold. And note, I am merely looking at this one from its future potential as a replacement for some others that have my attention now. So I am not putting this one down, just not in the camp that its going to justify a share price at the moment, at least until they commence the IDE... Cause I seriously doubt they would start the IDE without a high degree that the damn thing will actually work. But until then?? Its just an idea in progress to me. So did I miss out on a run? Yeah, but again, got others keeping me busy as my current priority.. Good luck.. Good luck, and watch the chart... news like this could dampen the enthusiasm, making it a potential 'trade' if it starts to slide. And yesterdays action is hinting the share price could be looking for the range seen around the 1st of the year ($1.75??) |
return to message board, top of board |